Incidence of and outcomes associ- ated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009;301:1779 89. 490. 2010 Advanced Cardiac Life Support Guidelines. Available at: http:// acls-algorithms.com/vfpulseless-vt. Accessed May 16, 2012. 491. Wever EF, Hauer RN, van Capelle FL, et al. Randomized study of im- plantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation. 1995;91:2195 203. 492. Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Ar- rest Study Hamburg). Am Heart J. 1994;127:1139 44. 493. Connolly SJ, Hallstrom AP, Cappato R, et al; for the AVID, CASH and CIDS studies: Antiarrhythmics vs Implantable Defibrillator study: Car- diac Arrest Study Hamburg: Canadian Implantable Defibrillator Study. Meta-analysis of the implantable cardioverter defibrillator secondary pre- vention trials. Eur Heart J. 2000;21:2071 8. 494. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investiga- tors. A comparison of antiarrhythmic-drug therapy with implantable defi- brillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576 83. 495. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibril- lator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297 302. 496. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Associa- tion Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008;117:e350 408. Erratum in: Circulation. 2009;120:e34 5. 497. Lopes RD, Elliott LE, White HD, et al. Antithrombotic therapy and out- comes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009;30:2019 28. 498. 